Company intelligence / Profile preview

Weijian Pharma

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Commercial-stage pharmaceutical company with over 20 marketed drugs focused on kidney and blood diseases, plus respiratory and dermatological conditions. Recently acquired Kyowa Kirin China for five innovative drugs and manufacturing facilities.[2]

Industry: Biotech

Partnerships

Kyowa Kirin (acquired China entity)LG Life Sciences (marketing rights for infertility drug)Over five global collaborators

Beyond the preview

Go deeper on Weijian Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weijian Pharma.

Explore the full profile